ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,433.76
0.63%
Dow Jones
39,486.38
0.25%
Gold vs US Dollar
2,368.105
0.91%
Brent Oil
82.795
-1.38%
Bitcoin
60,883.37
-3.44%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Innovation Pharmaceuticals Inc (CE) (IPIX)

  7. Innovation Pharmaceuticals Inc (CE) (IPIX) News

Innovation Pharmaceuticals (CE) (IPIX)

Innovation Pharmaceuticals Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:IPIX
DateTimeSourceHeadlineSymbolCompany
01/02/202413:30Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
05/12/202321:25Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
20/11/202321:05Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
15/11/202313:00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
30/10/202320:15Edgar (US Regulatory)Form 8-K - Current reportUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
28/09/202314:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
15/05/202313:02Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
15/02/202321:07Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
15/02/202312:31Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
04/01/202321:17Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
10/11/202221:09Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
28/09/202221:01Edgar (US Regulatory)Annual Report (10-k)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
28/09/202217:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
28/09/202217:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
28/09/202217:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
05/07/202221:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
15/06/202221:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
13/05/202221:12Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
09/11/202118:45Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
05/11/202114:20InvestorsHub NewsWireIQST Has Catalysts On Deck That Expose A Valuation Disconnect of Roughly 100% - Here's Why That Gap Should CloseUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
14/10/202122:01Edgar (US Regulatory)Current Report Filing (8-k)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
11/10/202112:00InvestorsHub NewsWireCEO Presenting on the Emerging Growth Conference on October 13 Register NowUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
29/09/202113:00InvestorsHub NewsWireCEO's Presenting on the Emerging Growth Conference 17 TODAY.  Register NowUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
28/09/202112:24InvestorsHub NewsWireCLS Holdings, (OTCQB: CLSH) New Joint Venture $19 million Sales 61% GrowthUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
21/07/202111:47InvestorsHub NewsWireNightfood, Inc. (OTCQB: NGTF) Significant Retail ExpansionUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
09/06/202112:00InvestorsHub NewsWireThe Emerging Growth Conference is Today.  Register Now.USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
13/05/202113:01Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
03/05/202117:54Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
09/03/202111:37InvestorsHub NewsWireCLS Holdings, (OTCQB: CLSH) $1.49 million Net Revenue for Feb Highest in Company HistoryUSOTC:IPIXInnovation Pharmaceuticals Inc (CE)
22/02/202116:20Edgar (US Regulatory)Quarterly Report (10-q)USOTC:IPIXInnovation Pharmaceuticals Inc (CE)
 Showing the most relevant articles for your search:USOTC:IPIX

Your Recent History

LSE
POS
Plexus
LSE
TERN
Tern
LSE
PET
Petrel Resources
LSE
SYME
Supply@me Capital
LSE
SFOR
S4 Capital
LSE
AAZ
Anglo Asian Mining
LSE
THG
Thg
LSE
ITV
Itv
LSE
POLX
Polarean Imaging
LSE
BOO
Boohoo
LSE
RR.
Rolls-royce
LSE
TXP
Touchstone Exploration
LSE
AGL
Angle
LSE
PANR
Pantheon Resources
LSE
CHLL
Chill Brands
LSE
GDR
Genedrive
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved